Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Vehiculum Capital is a partnership of families, founders, and operators based in Europe, specifically targeting the UK and EU markets. The firm focuses on deeptech investments and has a history of co-investing alongside prominent investors. They typically manage investments in early-stage companies with an average ticket size of $50,000.
Vehiculum Capital invests in pre-seed and seed stage companies, primarily in the biotech and semiconductor sectors. They engage in equity, SAFE, or convertible note investments, targeting startups with strong intellectual property development and early commercial traction.
Notable portfolio companies include Xterna, a biotech firm developing drug targeting technology; ChipFlow, which focuses on custom microchip development; Prosper, a fintech company optimizing wealth management; and Invitris, known for creating protein-based drugs to combat antibiotic resistance.
Email relations@markovian.group with your deck to pitch Vehiculum Capital.
Vehiculum Capital often participates in co-investments alongside other prominent investors, but they may lead rounds depending on the opportunity.
The firm typically evaluates follow-on investments based on the startup's progress and alignment with their investment thesis.
Specific fund size details are not disclosed, but they focus on early-stage investments with an average check size of $50,000.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.